Social determinants of health: A forgotten risk factor for neurocognition in pediatric brain tumor survivors
- PMID: 37486932
- PMCID: PMC10547504
- DOI: 10.1093/neuonc/noad127
Social determinants of health: A forgotten risk factor for neurocognition in pediatric brain tumor survivors
Conflict of interest statement
M. Hall: Honorarium from Ion Beam Applications; research support from the Live Like Bella Pediatric Research Initiative, Florida Department of Health, Grants 8LA04 and 22L01. R. Kotecha: Honoraria from Accuray Inc., Elekta AB, ViewRay Inc., Novocure Inc., Elsevier Inc., Brainlab, Kazia Therapeutics, Castle Biosciences, Ion Beam Applications; institutional research funding from Medtronic Inc., Blue Earth Diagnostics Ltd., Novocure, Inc., GT Medical Technologies, AstraZeneca, Exelixis, ViewRay, Inc., Brainlab, Cantex Pharmaceuticals, Kazia Therapeutics, and Ion Beam Applications.
Comment on
-
Social determinants of cognitive outcomes in survivors of pediatric brain tumors treated with conformal radiation therapy.Neuro Oncol. 2023 Oct 3;25(10):1842-1851. doi: 10.1093/neuonc/noad080. Neuro Oncol. 2023. PMID: 37099477 Free PMC article.
References
-
- Robinson KE, Kuttesch JF, Champion JE, et al. A quantitative meta-analysis of neurocognitive sequelae in survivors of pediatric brain tumors. Pediatr Blood Cancer. 2010; 55(3):525–531. - PubMed
-
- Merchant TE, Kiehna EN, Kun LE, et al. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg. 2006; 104(2 suppl):94–102. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
